Please login to the form below
Tonic Life expands into Asia
Tonic Life Communications has expanded into Asia with the launch of its Hong Kong office. Joanne Basford has been appointed managing director
Tonic Life Communications has expanded into Asia with the launch of its first Hong Kong office. Joanne Basford has been appointed managing director and will work closely with the rest of the Huntsworth network – including Grayling and Citigate, which are already established in APAC.
Tonic CEO, Scott Clark, said: "Tonic already has a number of international clients that have been seeking our support in Asia and by opening this office we will be well-placed to offer local insight coupled with world-class talent and campaigns."
"From a regional hub in Hong Kong we will drive not only regional campaigns for our clients, but will be further developing our business with additional offices in Singapore and Shanghai planned for the near future."
Tonic was founded in 2004 and acquired by Huntsworth Plc in 2009. It works in the areas of lifesciences (prescription medicines and devices) and lifestyle (consumer health and well-being brands) with a particular focus on where the two areas intersect. It currently has offices in London and the US, and now Hong Kong.
Share
Related Hub content
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Adaptive innovation
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- Navigating patients step by step on their clinical trial journey
No results were found
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
